MEDS 8-K: SEC filing

Filed with the SEC on Nov 13, 2026 · accession 0001493152-26-051734

MEDS filed a 8-K (current report) with the SEC on Nov 13, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -14.5% by the first close after the filing.

Summary of the filing

DataMEDS AI, Inc. furnished a press release announcing its financial results for the third quarter ended September 30, 2026, along with a business update.

For details, click here →How to read a 8-K →

Key details

RegistrantDataMEDS AI, Inc.

PresidentPrashant Patel

How MEDS stock reacted

Close before

$0.87

Nov 12, 2026

First close after

-14.51%

$0.74

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MEDS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MEDS?

Click here

Frequently asked questions

What did MEDS file with the SEC on Nov 13, 2026?

MEDS filed a 8-K (SEC filing). DataMEDS AI, Inc. furnished a press release announcing its financial results for the third quarter ended September 30, 2026, along with a business update.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did MEDS stock react to this filing?

MEDS closed at $0.87 before the filing and $0.74 on Nov 13, 2026 (-14.51%).

Other MEDS SEC filings

Get alerts when MEDS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

MEDS overview MEDS analysis MEDS news Latest SEC filings